CLINICAL TRIALS PROFILE FOR FERRIC MALTOL

All Clinical Trials for ferric maltol

Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT01340872 ↗	Safety and Efficacy Study of Oral Ferric Iron To Treat Iron Deficiency Anaemia in Quiescent Ulcerative Colitis (AEGIS-1)	Completed	Iron Therapeutics	Phase 3	2011-08-01	The purpose of this study is to determine whether ST10-021, an oral ferric iron preparation, is safe and effective in the treatment of iron deficiency anaemia (IDA) in subjects with non-active ulcerative colitis (UC).
NCT01340872 ↗	Safety and Efficacy Study of Oral Ferric Iron To Treat Iron Deficiency Anaemia in Quiescent Ulcerative Colitis (AEGIS-1)	Completed	Shield Therapeutics	Phase 3	2011-08-01	The purpose of this study is to determine whether ST10-021, an oral ferric iron preparation, is safe and effective in the treatment of iron deficiency anaemia (IDA) in subjects with non-active ulcerative colitis (UC).
NCT01352221 ↗	Safety and Efficacy Study of Oral Ferric Iron To Treat Iron Deficiency Anaemia in Quiescent Crohn's Disease (AEGIS-2)	Completed	Iron Therapeutics	Phase 3	2011-08-01	The purpose of this study is to determine whether ST10-021, an oral ferric iron preparation, is safe and effective in the treatment of iron deficiency anaemia (IDA) in subjects with non-active Crohn's Disease (CD).
NCT01352221 ↗	Safety and Efficacy Study of Oral Ferric Iron To Treat Iron Deficiency Anaemia in Quiescent Crohn's Disease (AEGIS-2)	Completed	Shield Therapeutics	Phase 3	2011-08-01	The purpose of this study is to determine whether ST10-021, an oral ferric iron preparation, is safe and effective in the treatment of iron deficiency anaemia (IDA) in subjects with non-active Crohn's Disease (CD).
NCT02680756 ↗	Safety and Efficacy Study of Oral Ferric Maltol Compared to Intravenous Iron To Treat Iron Deficiency Anaemia in IBD	Completed	Iron Therapeutics	Phase 3	2016-01-01	The purpose of this study is to compare the efficacy of ferric maltol and intravenous iron (IVI) Ferric Carboxy Maltose in the treatment of iron deficiency anaemia (IDA) and subsequent maintenance of haemoglobin in subjects with Inflammatory Bowel Disease (IBD).
NCT02680756 ↗	Safety and Efficacy Study of Oral Ferric Maltol Compared to Intravenous Iron To Treat Iron Deficiency Anaemia in IBD	Completed	Shield Therapeutics	Phase 3	2016-01-01	The purpose of this study is to compare the efficacy of ferric maltol and intravenous iron (IVI) Ferric Carboxy Maltose in the treatment of iron deficiency anaemia (IDA) and subsequent maintenance of haemoglobin in subjects with Inflammatory Bowel Disease (IBD).

Clinical Trial Conditions for ferric maltol

Condition Name

Condition Name for ferric maltol
Intervention	Trials
Anemia, Iron Deficiency	4
Inflammatory Bowel Disease	3
Iron-deficiency	3
Iron Deficiency Anaemia	2

Condition MeSH

Condition MeSH for ferric maltol
Intervention	Trials
Anemia, Iron-Deficiency	11
Anemia	7
Intestinal Diseases	4
Inflammatory Bowel Diseases	4

Clinical Trial Locations for ferric maltol

Trials by Country

Trials by Country for ferric maltol
Location	Trials
United States	34
Germany	4
United Kingdom	3
Puerto Rico	1
Belgium	1

Trials by US State

Trials by US State for ferric maltol
Location	Trials
Florida	3
Texas	3
Ohio	2
Arizona	2
Alabama	2

Clinical Trial Progress for ferric maltol

Clinical Trial Phase

Clinical Trial Phase for ferric maltol
Clinical Trial Phase	Trials
Phase 4	3
Phase 3	7
Phase 1	2

Clinical Trial Status

Clinical Trial Status for ferric maltol
Clinical Trial Phase	Trials
Completed	5
Not yet recruiting	3
Recruiting	2

Clinical Trial Sponsors for ferric maltol

Sponsor Name

Sponsor Name for ferric maltol
Sponsor	Trials
Shield Therapeutics	7
Iron Therapeutics	4
Hannover Medical School	3

Sponsor Type

Sponsor Type for ferric maltol
Sponsor	Trials
Industry	14
Other	10